Have a personal or library account? Click to login
Evaluation of interleukin-6 concentration in the liver of Albino Swiss mice after intoxication with various doses of patulin Cover

Evaluation of interleukin-6 concentration in the liver of Albino Swiss mice after intoxication with various doses of patulin

Open Access
|Apr 2019

References

  1. 1. Puel O, Galtier P, Oswald IP. Biosynthesis and Toxicological Effects of Patulin. Toxins. 2010;2(4):613-31.10.3390/toxins2040613315320422069602
  2. 2. Bennet JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3):497-516.10.1128/CMR.16.3.497-516.200316422012857779
  3. 3. Chełkowski J. Mikotoksyny, grzyby toksynotwórcze i mikotoksykozy. http://www.cropnet.pl/dbases/mycotoxins.pdf.pl/download. 2010, [accessed 2010 June 20].
  4. 4. Wilson DM, Mubatanhema W, Jurjevic Z. Biology and ecology of mycotoxigenic Aspergillus species as related to economic and health concerns. Adv Exp Med Biol. 2002;504:1-17.10.1007/978-1-4615-0629-4_211922097
  5. 5. Balas J. Mikotoksyny jako źródło zanieczyszczeń żywności pochodzenia roślinnego. Postępy Fitoterapii. 2006;2:98-104.
  6. 6. Grajewski J. Mikotoksyny i grzyby pleśniowe. Zagrożenie dla człowieka i zwierząt. Bydgoszcz. Wyd. UKW, 2006.
  7. 7. Jarzynka S, Dąbkowska M, Netsvyetayeva I, Swoboda-Kopeć E. Mikotoksyny – niebezpieczne metabolity grzybów pleśniowych. Medycyna Rodzinna. 2010;4:113-9.
  8. 8. Santini A, Raiola A, Meca G, Ritieni A. Aflatoxins, Ochratoxins, Trichotecenes, Patulin, Fumonisins and Beauvericin in Finished Products for Human Consumption. J Clin Toxicol. 2015;5(4):2-11.10.4172/2161-0495.1000265
  9. 9. Szymczyk K, Szteke B, Goszcz H. Występowanie patuliny w krajowych sokach jabłkowych. Roczn PZH. 2004;55(3):255-60.
  10. 10. Kurpińska-Jaworska J, Ledzion E, Szczęsna M, Karłowski K, Postupolski J, Rybińska K. Nowe przepisy Unii Europejskiej w zakresie patuliny. Roczn PZH. 2003;54(4): 355-61.
  11. 11. Rozporządzenie Komisji Wspólnoty Europejskiej NR 1881/2006 z dnia 19 grudnia 2006 r. ustalające najwyższe dopuszczalne poziomy niektórych zanieczyszczeń w środkach spożywczych. L364 5-24.
  12. 12. Wróbel B. Zagrożenia zwierząt i ludzi toksynami grzybów pleśniowych zawartych w paszach i żywności. Woda-Środowisko-Obszary Wiejskie. 2014;14:159-76.
  13. 13. Al-Hazmi MA. Patulin in apple juice and its risk assessments on albino mice. Toxicol Ind Health. 2014;30(6):534-45.10.1177/074823371245745423012343
  14. 14. Arzu Koçkaya E, Selmanoğlu G, Ozsoy N, Gül N. Evaluation of patulin toxicity in the thymus of growing male rats. Arh Hig Rada Toksikol. 2009;60:411-8.10.2478/10004-1254-60-2009-197320061241
  15. 15. Bouhet S, Oswald IP. The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response. Vet Immunol Immunopathol. 2005;108:199-209.10.1016/j.vetimm.2005.08.01016144716
  16. 16. Glaser N, Stopper H. Patulin: Mechanism of genotoxicity. Food Chem Toxicol. 2012;50(5):1796-801.10.1016/j.fct.2012.02.09622425938
  17. 17. Grajewski J, Twarużek M. Zdrowotne aspekty oddziaływania grzybów pleśniowych i mikotoksyn. Alergia. 2004;3:45-9.
  18. 18. Ozsoy N, Selmanoğlu G, Koçkaya EA, Gül N, Cebesoy S. Effect of patulin on the interdigitating dendritic cells (IDCs) of rat thymus. Cell Biochem Funct. 2008;26(2):192-6.10.1002/cbf.143117702051
  19. 19. Pfeiffer E, Diwald TT, Metzler M. Patulin reduces glutathione level and enzyme activities in rat liver slices. Mol Nutr Food Res. 2005;49(4):329-36.10.1002/mnfr.20040008915744717
  20. 20. Roll R, Matthiaschk G, Korte A. Embryotoxicity and mutagenicity of mycotoxins. J Environ Pathol Toxicol Oncol. 1990;10:1-7.
  21. 21. Mahfoud R, Maresca M, Garmy N, Fantini J. The mycotoxin patulin alters the barrier function of the intestinal epithelium: mechanism of action of the toxin and protective effects of glutathione. Toxicol Appl Pharmacol. 2002;15,181(3):209-18.10.1006/taap.2002.9417
  22. 22. Maresca M, Yahi N, Younès-Sakr L, Boyron M, Caporiccio B, Fantini J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: Stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol Appl Pharmacol. 2008;228:84-92.10.1016/j.taap.2007.11.01318308354
  23. 23. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1997;206:30-9.10.1097/00000658-198707000-00005
  24. 24. Nagwa M, El-Sawi NM, Gashlan HM, Younes SH, Al-Massabi RF, Shaker S. Biochemical and histological studies on the effect of the Patulin mycotoxin on male rats’ liver and treatment by crude venom extracted from jelly fish. Life Sci J. 2012;9(4):1143-53.
  25. 25. Song E, Xia X, Su C, Dong W, Xian Y, Wang W, et al. Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration. Food Chem Toxicol. 2014;71:122-7.10.1016/j.fct.2014.06.009
  26. 26. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63:321-9.10.1111/j.1365-3083.2006.01750.x16640655
  27. 27. Wichmann G, Herbarth O, Lehmann I. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ Toxicol. 2002;17:211-8.10.1002/tox.10050
  28. 28. Seidelin JB, Bjerrum JT, Coskun M, Widjaya B, Vainer B, Nielsen OH. IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol. Lett. 2010;128:80-5.10.1016/j.imlet.2009.11.001
  29. 29. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006:8(2):2-8.10.1186/ar1917
  30. 30. Gaini S, Koldkjaer OG, Pedersen C. Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care. 2006:10:53.
  31. 31. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-68.10.1016/S1359-6101(02)00027-8
  32. 32. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol. 2010;22(5):347-52.10.1093/intimm/dxq03020410258
  33. 33. Scheller J, Ohnesorge N, Rose-John S. Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol. 2006;63:321-9.10.1111/j.1365-3083.2006.01750.x
  34. 34. Bondy GS, Pestka JJ. Immunomodulation by fungal toxins. J Toxicol Environ Health. 2000;3(2):109-43.10.1080/10937400028111310834078
  35. 35. Dziennik Urzędowy Unii Europejskiej. L50/8 z 27.02.2010.
  36. 36. Gashlan HM. Biochemical Studies of Patulin on Liver Functions in Male Albino Mice. J Apple Anim Res. 2008;34(1):93-6.10.1080/09712119.2008.9706947
  37. 37. Walusia J, Gutarowska B, Żakowska Z, Pałczyński C. Grzyby Pleśniowe w środowisku komunalnym i w miejscu pracy – istotne zagrożenie zdrowotne. Medycyna Pracy. 2004;55(3):257-66.
  38. 38. Luft P, Oostingh GJ, Gruijthuijsen Y, Horejs-HoeckJ, Lehmann I, Duschl A. Patulin Influences the Expression of Th1/Th2 Cytokines by Activated Peripheral Blood Mononuclear Cells and T Cells Through Depletion of Intracellular Glutathione. Environ Toxicol. 2008;23:84-95.10.1002/tox.20309
  39. 39. Puel O, Tadrist S, Delaforge M, Oswald IP, Lebrihi A. The inability of Byssochlamys fulva to produce patulin is related to absence of 6-methylsalicylic acid synthase and isoepoxydon dehydrogenase genes. Int J Food Microbiol. 2007;115:131-9.10.1016/j.ijfoodmicro.2006.10.016
  40. 40. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006;8(2):2-8.10.1186/ar1917
  41. 41. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-68.10.1016/S1359-6101(02)00027-8
  42. 42. Urbanowicz W. Rola wątroby w odpowiedzi ostrej fazy. Postępy Nauk Medycznych. 2000;1:46-9.
  43. 43. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 2004;113:1251-3.10.1172/JCI2144139843515124013
  44. 44. Koczy-Baron E, Kasperska-Zając A. Rola naczyniowo-śródbłonkowego czynnika wzrostu w procesach zapalnych. Postępy Hig Med Dośw. 2014;68:57-65.10.5604/17322693.108636024491896
  45. 45. Zhang Y, Matsuo H, Morita E. Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch Dermatol Res. 2006;297:425-9.10.1007/s00403-006-0641-916456664
DOI: https://doi.org/10.2478/cipms-2019-0008 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 34 - 39
Submitted on: May 20, 2018
|
Accepted on: Jul 6, 2018
|
Published on: Apr 6, 2019
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Pawel Borzecki, Agnieszka Borzecka, Patrycja Chylinska-Wrzos, Marta Lis-Sochocka, Ewelina Wawryk-Gawda, Barbara Jodlowska-Jedrych, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.